Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
149.88
+2.88 (1.96%)
Mar 4, 2026, 4:00 PM EST - Market closed
Insmed Stock Forecast
Stock Price Forecast
The 22 analysts with 12-month price forecasts for Insmed stock have an average target of 188.73, with a low estimate of 115 and a high estimate of 241. The average target predicts an increase of 25.92% from the current stock price of 149.88.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock from 23 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 12 | 12 | 12 |
| Buy | 7 | 7 | 9 | 10 | 9 | 9 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 21 | 24 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $211 → $204 | Buy | Maintains | $211 → $204 | +36.11% | Feb 24, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $230 | Strong Buy | Reiterates | $230 | +53.46% | Feb 23, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $234 → $208 | Buy | Maintains | $234 → $208 | +38.78% | Feb 20, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $157 → $162 | Hold | Maintains | $157 → $162 | +8.09% | Jan 30, 2026 |
| Barclays | Barclays | Buy Initiates $231 | Buy | Initiates | $231 | +54.12% | Jan 28, 2026 |
Financial Forecast
Revenue This Year
1.63B
from 606.42M
Increased by 168.46%
Revenue Next Year
2.70B
from 1.63B
Increased by 65.97%
EPS This Year
-2.93
from -6.42
EPS Next Year
0.48
from -2.93
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.0B | 3.8B | |||
| Avg | 1.6B | 2.7B | |||
| Low | 949.6M | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 236.7% | 130.7% | |||
| Avg | 168.5% | 66.0% | |||
| Low | 56.6% | 16.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.65 | 3.59 | |||
| Avg | -2.93 | 0.48 | |||
| Low | -4.20 | -1.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.